Isophotal Shapes of Early-type Galaxies to Very Faint Levels

We report on a study of the isophotal shapes of early-type galaxies to very faint levels, reaching ~0.1% of the sky brightness. The galaxies are from the Large Format Camera (LFC) fields obtained using the Palomar 5 m Hale Telescope, with integrated exposures ranging from 1 to 4 hr in the Sloan Digital Sky Survey r, i, and z bands. The shapes of isophotes of early-type galaxies are important, as they are correlated with the physical properties of the galaxies and are influenced by galaxy formation processes. In this paper, we report on a sample of 132 E and SO galaxies in one LFC field. We have redshifts for 53 of these, obtained using AAOmega on the Anglo-Australian Telescope. The shapes of early-type galaxies often vary with radius. We derive average values of isophotal shape parameters in four different radial bins along the semi-major axis in each galaxy. We obtain empirical fitting formulae for the probability distribution of the isophotal parameters in each bin and investigate for possible correlations with other global properties of the galaxies. Our main finding is that the isophotal shapes of the inner regions are statistically different from those in the outer regions. This suggests that the outer and inner parts of early-type galaxies have evolved somewhat independently

Design and Development of Automatic Operated Seeds Sowing Machine

The area of agriculture is so wide, therefore this field requires the advance technologies in the process of sowing, cropping, cutting. This advancement in technology will not affect the quality of soil and increase the efficiency of getting crop. During the seed sowing process the feeding of seed as well as fertilizer is pour. Now a days the availability of labor is a major problem faced by farmer. We demonstrate that the easy method for seed sowing. In this work we replace complicated gear system by hall effect sensor for easier and costlier seed sowing and also reduce a need of labor. The Hall Effect sensor convert rotation into distance for which seed sowing at particular distance. Also there is adjustable system for sowing at different distance. By using this machine the sowing can be done row by row and distance will maintain. So this machine reduces their efforts and reduces the cost of seed sowing process with great efficiency and accuracy with reducement in labor requirement

A pharmacovigilance study in patients of chronic non-infective respiratory diseases attending outpatient department of pulmonary medicine in a tertiary care teaching hospital

Background: Adverse drug reactions (ADR) are the known dangers of any medicinal therapy. They are not only responsible for increasing the mortality and morbidity but also for multiplying the health care expenditure. It is important to monitor the adverse effects of the drugs in the patients on treatment for chronic non-infective respiratory diseases attending OPD of pulmonary medicine in a tertiary care teaching hospitalMethods: The study was single-centric, non-randomized and observational hospital-based study which was carried out for a period of 1 and a half years in JJ Hospital. The patients who were included in the study suffered from either of the 4 diseases-Chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis or interstitial lung diseases (ILD). Data were analyzed by using Microsoft excel sheet. Based on the outcome of modified Hartwig and Siegel severity assessment scale, ADRs were grouped into various severity categories.Results: One hundred and thirty-two number of ADRs were seen in 69 out of 352 patients (19.6 %) of the study population. The occurrence of ADR was found slightly higher in males i.e., 53.62% as compared to females i.e., 46.38%. The patients who were on treatment for ILD showed highest percentage of ADRs i.e., 57.89% which is followed by bronchiectasis (17.39%), COPD (16.17%) and lastly asthma (10.26%). The ADRs belonging to GIT system were highest in number i.e., 80. The most frequently occurring ADR in the study was palpitation which occurred in 14 cases i.e., 20.29%. Out of 132 ADRs observed, 96 i.e., 72.73% belonged to the mild category and 36 ADRs i.e., 27.27% belonged to the moderate category. Not a single severe ADR was found in the study.Conclusions: It was found that 19.6% of the patient population suffered from ADRs, which is a considerable number. It is essential that health care professionals should support ADR monitoring process for the safety of the medicinal product. Proper implementation of ADR monitoring will help to reduce the harmful effects by early detection of drug safety problems in patients, assessing the risk-benefit in an individual and the population, improving the selection, rational use of drugs through the provision of timely warning to healthcare professionals

Remote Data Acquisition and Visualization on an App

In order to allow power consumers to have a better understanding of their industrial electricity, it is necessary to provide them with real-time electricity information. Now a days we need to do meter reading, analysis manually. If any meter is goes down or fluctuating we need to do manual servicing and troubleshooting. It may cause meter loss, Time loss, and financial loss. The platform enables power consumers to have a better understanding of their own electricity consumption status and reasonable arrangements for use of electricity. Its deployment is very simple. For users, they do not need to change the household electricity structure. They can easily view the home electricity information and real-time monitor and control after installing power information visualization APP on their mobile phones or other mobile terminals. User interaction needs to collect power information of all equipment, and provide users with real-time electricity price and electricity information. The basic purpose of system is M-Measure, A-Analysis, R-Record, and CControl. No human intervention for data processing analysis. This is use for Power quality analysis, Identification and prevention of downtime of assets, Alarms and triggers are used for preventive control to avoid loss. Reduce the losses by monitoring and controlling the power quality. Accurate analytics depending on the load connected to the system. It supports most of all make sensors and hardware meters to work with the system. Periodical analysis of the organization for the complete energy health check-up

Heterogeneous 2.5D integration on through silicon interposer

© 2015 AIP Publishing LLC. Driven by the need to reduce the power consumption of mobile devices, and servers/data centers, and yet continue to deliver improved performance and experience by the end consumer of digital data, the semiconductor industry is looking for new technologies for manufacturing integrated circuits (ICs). In this quest, power consumed in transferring data over copper interconnects is a sizeable portion that needs to be addressed now and continuing over the next few decades. 2.5D Through-Si-Interposer (TSI) is a strong candidate to deliver improved performance while consuming lower power than in previous generations of servers/data centers and mobile devices. These low-power/high-performance advantages are realized through achievement of high interconnect densities on the TSI (higher than ever seen on Printed Circuit Boards (PCBs) or organic substrates), and enabling heterogeneous integration on the TSI platform where individual ICs are assembled at close proximity

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.